Cipla gets no USFDA observations for Indore facility Farhat Nasim18 May 2019 4:15 AM GMTThe US health regulator conducted a post-approval inspection at Cipla Ltd's Indore facility from 13th May to 17th May 2019. New Delhi: Drug firm Cipla...
USFDA completes audit for Dr Reddys Shreveport plant, no observations issued Medical Dialogues Bureau23 Feb 2019 4:00 AM GMT"The audit of our formulations Shreveport plant, Louisiana, USA, by the United States Food and Drug Administration (USFDA) has been completed with...
Dr Reddy's Lab shares gain 3 percent on zero USFDA observations for Srikakulam plant Ruby Khatun Khatun5 Jun 2018 5:00 AM GMTNew Delhi: Shares of Dr Reddys Laboratories rose by nearly 3 percent after the company said the USFDA has completed its API Srikakulam plant audit...
Dr Reddys receives EIR for Srikakulam plant, shares soar Ruby Khatun Khatun22 Sep 2017 4:59 AM GMTNew Delhi: Shares of Dr Reddy's Laboratories Ltd soared by 7.5% after the company said it has received establishment inspection report (EIR) from the...